CPhI Russia Pharma Expo to be held at St. Petersburg from 16 to 17 April, 2014

The slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers, which are now shifting their focus towards regional exports. Mirroring this trend, international investors and companies are increasingly looking at more business access in Indonesia and across the entire ASEAN economy. The country has the biggest and fastest growing economy in the SEA region and a pharma market comprising approximately pharmaceutical companies. There are already generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies, such as Sanofi, ACG and Novo Nordisk, established in the area. Most significantly however, are the remaining domestic manufacturers, which are increasing targeting international sales in neighbouring countries. These favourable macro trends are reflected at CPhI South East Asia where domestic manufacturers are increasingly attending the event, with a view to opening up sales in international markets. Co-locating this year with P-MEC, InnoPack, and the returning ICSE and Health Ingredients South East Asia, the event welcomes the best pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing as well as nutraceutical companies from across the region.

Duco, ventilation & sun control – Professionals – Home

The slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers, which are now shifting their focus towards regional exports. Mirroring this trend, international investors and companies are increasingly looking at more business access in Indonesia and across the entire ASEAN economy.

The country has the biggest and fastest growing economy in the SEA region and a pharma market comprising approximately pharmaceutical companies. There are already generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies, such as Sanofi, ACG and Novo Nordisk, established in the area. Most significantly however, are the remaining domestic manufacturers, which are increasing targeting international sales in neighbouring countries.

CPhI Japan is a five-in-one event allowing visitors to gain access to the entire Japanese pharma industry under one roof, and meet with exhibitors working across ingredients, contract services, biopharmaceuticals, machinery, technology, and packaging.

The 25th edition of ProPak China is going to be held in Hall 5. The buyers will be spoiled for choice as they will be presented with packaging material and container, packaging machinery, food processing, liquid processing, weighing and metering equipment, industrial robot, warehouse logistics and quality inspection equipment. In , both these shows will be organized concurrently with a series of brand exhibitions under UBM, including nutrition and health products, starch, health and food ingredients, agricultural and animal raising technologies and equipment.

Get ready to travel to Shanghai to be a part of the whole-industry processing and packaging exhibition in food and pharmacy industries in exhibition halls in West and East Shanghai simultaneously. The total area of the exhibitions will be more than , m2, and attract over 5, exhibitors and , professional visitors. Exhibitor’s Profile ProPak China held for 24 session in past has become a professional show of the packaging technology and equipment industry.

Every year, the number of professional participants rise. In edition, participation of more than 25, professional visitors is expected. The supporting events organized along with the show, like special forums, matchmaking, innovative products demonstration, etc.

A History: ’s Word of the Year

Mirroring this trend, international investors and companies are now pushing for more business in this regional market, across the entire ASEAN economy. The country has the biggest and fastest-growing economy in the SEA region and a pharma economy consisting of over pharmaceutical companies. There are already generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies established in the area.

These favourable macro trends will be reflected at CPhI South East Asia where domestic manufacturers in particular are increasingly attending the event, with a view to opening up sales in international markets. The biggest pharma event in the ASEAN region, CPhI South East Asia will gather over 5, attendees from 41 countries and more than exhibitors click here for the full list to network, learn and do business for three days.

According to the CPhI report, the Japanese economy is opening to generics and overseas manufactured pharmaceutical products, opening the doors on a large, well-funded market. This opening is the result of both deregulation, and public interest in reducing health-care costs.

The slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers, which are now shifting their focus towards regional exports. Mirroring this trend, international investors and companies are increasingly looking at more business access in Indonesia and across the entire ASEAN economy. The country has the biggest and fastest growing economy in the SEA region and a pharma market comprising approximately pharmaceutical companies.

There are already generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies, such as Sanofi, ACG and Novo Nordisk, established in the area. Most significantly however, are the remaining domestic manufacturers, which are increasing targeting international sales in neighbouring countries. These favourable macro trends are reflected at CPhI South East Asia where domestic manufacturers are increasingly attending the event, with a view to opening up sales in international markets.

Co-locating this year with P-MEC, InnoPack, and the returning ICSE and Health Ingredients South East Asia, the event welcomes the best pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing as well as nutraceutical companies from across the region. The event is supported by the national and regional governments and regional trade groups, such as: We are seeing a strong interest from international companies coming to the event looking to do business not only in Indonesia, but in the entire ASEAN economy.

Additionally, in the last few years, more and more Indonesian regional manufacturers are using the event as an essential conduit to begin established sales outside their core domestic market. The establishment of the AEC, the introduction of universal healthcare programmes and hundreds of established domestic manufacturers is fuelling interest in sales across the region. For more information please visit:

UBM Blog/Forum

A press conference was held on March 16th and saw the participation of Mr. Several key topics, relevant to the region, were discussed. In fact, the slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers which are now shifting their focus more on the actual prospects of regional exports.

Mirroring this trend, international investors and companies are now pushing for more business in this regional market, across the entire ASEAN economy.

The CPhI North America Matchmaking Pass Tight on resources and short on time? If you’re a pharma supplier who feels having a booth in our expo hall might not be the right fit this year, you can still take full advantage of all the show floor’s networking opportunities with the all-access Matchmaking Pass!

The slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers, which are now shifting their focus towards regional exports. Mirroring this trend, international investors and companies are increasingly looking at more business access in Indonesia and across the entire ASEAN economy. The country has the biggest and fastest growing economy in the SEA region and a pharma market comprising approximately pharmaceutical companies.

There are already generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies, such as Sanofi, ACG and Novo Nordisk, established in the area. Most significantly however, are the remaining domestic manufacturers, which are increasing targeting international sales in neighbouring countries. These favourable macro trends are reflected at CPhI South East Asia where domestic manufacturers are increasingly attending the event, with a view to opening up sales in international markets.

Co-locating this year with P-MEC, InnoPack, and the returning ICSE and Health Ingredients South East Asia, the event welcomes the best pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing as well as nutraceutical companies from across the region. The event is supported by the national and regional governments and regional trade groups, such as: We are seeing a strong interest from international companies coming to the event looking to do business not only in Indonesia, but in the entire ASEAN economy.

Additionally, in the last few years, more and more Indonesian regional manufacturers are using the event as an essential conduit to begin established sales outside their core domestic market. The establishment of the AEC, the introduction of universal healthcare programmes and hundreds of established domestic manufacturers is fuelling interest in sales across the region.

Site Archive for Thursday, 06 Nov 2014

Held annually in Verona, Italy, the trade show is the focal point for developments, innovations and knowledge transfer in the sector. It is a dedicated expo for trade visitors and media outlets ensuring all attendees will receive the best value from the event. Marmomacc is a central hub for knowledge transfer and business matchmaking as well. Award ceremonies, key industry lectures and presentations, and the annual General Assembly of the European Association of “Agglomerated Stones” producers complement the exhibition with unparalleled insightful information that is defining the sector for the entire year.

To make sure you will face no troubles securing a hotel near the venue or the city center, our team at Fair Point prepared a big list of individual hotels and world leading hotel chains that we have contracts with.

Cphi – Exhibitor List Compiled; CPhI Matchmaking Stand CPhI Matchmaking Stand CPhI Rebook Stand CPhI Worldwide Sales Stand Cremer Oleo GmbH & Croda Europe Limited CS Bio Company Inc CSPC ZHONGNUO PHARMACEUTICAL CO., LTD CSPC ZHONGNUO PHARMACEUTICAL CO., LTD CTX Life Sciences Pvt. Ltd.

This new event will open at the 27th CPhI Worldwide in Barcelona October and reflects the huge growth in finished dosage formulations across the wider pharma market. It will act as a global meeting-point for any company looking to grow, launch or distribute finished formulations in international or national markets. Over the last few years, sales in the pharmaceutical supply chain have accelerated across commercial supply and final dosage forms, where more complex solutions and higher margin products are common.

Pharma companies seeking partners with new formulations, and the rise in complex and difficult to formulate compounds are driving the growth in this market. Additionally, CPhI stated, generics and the increasing use of out-licensed formulations are a key factor behind its decision. In fact, since the introduction of the FDF zone at CPhI Worldwide in , it has quickly grown to be the third largest part of the show totalling over 11, m2 in Dosage forms represented will cover all types of solid dose, semi-solids, liquids, sprays and steriles from both pharma and biologics companies, including tablets, capsules, gels, parenteral drugs, vials, patches, creams, inhalation, nasal, sublingual and suppository.

And, both within the wider market and in terms of exhibitor numbers, it is one of the fastest growing areas in pharma. We are the leading Western producer of heparin the world’s most commonly used anticoagulant and antithrombotic and leaders in osteoarthritis and joint health. Topics will include everything from the regulatory approvals, processes and changes, to key growth markets, new formulation technologies, distribution and commercialisation.

In practical terms, this means we have created new content, sessions, networking and the best new business opportunities in one place. This way our attendees and exhibitors can more quickly identify leads through our company matchmaking platform and move between potential clients and customers. By launching FDF, we are creating the ideal set of conditions for exploring this thriving sector.

Duco, ventilation & sun control – Professionals – Home

Russia is benefiting from a growing economy and with the increased healthcare investments being made by the government, the market is set to enjoy a sustained and prolonged period of expansion. CPhI Russia IPhEB and its co-located events provide the ideal platform to break into this attractive region, with both domestic and international buyers and suppliers all looking to meet, network and drive the Russian market.

This year’s platinum partner, JSC “Pharmasyntez” exemplifies the growth in the region, through their multi-million dollar investments in domestic drug production – with three new sites opening in The company will feature as an exhibitor at the event, showcasing their new dosage form capabilities – sterile powders and solutions for injection.

Alongside JSC “Pharmasyntez”, the total number of exhibitors vastly exceeds that of last year, rising from 65 exhibitors to more than

CPhI Connect Conference Program. InformEx Connect Conference Program. Keynote Session. General Session. Conference Content Post Show. Expo Floor. Matchmaking Solution. Innovation & Product Gallery. Exhibitor Showcases. Insight Briefings. Welcome Reception. Daily Breakfast and Lunch CPhI North America Has Strategically Partnered With.

Taking place th March , the five-in-one event is expected to bring together over pharma industry leaders from 82 countries and exhibitors. A rapidly emerging MENA biologics industry in both Turkey and the wider region sees key trends in biopharmaceutical, biosimilars and biobetters debated. The Biopharma conference launching at CPhI Istanbul is being undertaken with the full backing of local and national Government.

It will see three days of content-led sessions and speakers and delegates discuss the opportunities for companies in Turkey and the MENA region. Turkey is now the fastest growing economy in the OCED and already posses the 8th largest pharma market in Europe. The 12 sessions will analyse and discuss business critical and pharma market issues, with limited slots for 10 attendees at a time.

Featured highlights at CPhI Istanbul include: After a successful first edition in , the Matchmaking programme returns to help create new opportunities for the development of new business leads and collaborations. Organised by Fortune Turkey, the Women networking meet-up gathers female executives from across the MENA pharma network to share experiences, trade knowledge, while exchanging leadership strategies from inspirational industry professionals. The Exhibitor seminars will see exhibiting companies present their most innovative products and services to the media and visitors on the show floor.

For more information please visit: Through exhibitions, conferences and online communities, CPhI brings together more than , pharmaceutical professionals each year to network, identify business opportunities and expand the global market.

Growth In Finished Dosage Formulations Sees CPhI Worldwide Introduce New Event

It is an opportunity for us to reflect on the language and ideas that represented each year. So, take a stroll down memory lane to remember all of our past Word of the Year selections. Change It wasn’t trendy , funny, nor was it coined on Twitter , but we thought change told a real story about how our users defined Unlike in , change was no longer a campaign slogan.

But, the term still held a lot of weight. Here’s an excerpt from our Word of the Year announcement in

Sponsored by UBM Live & UBM Sinoexpo,EXPO FoodTec will be hold in SNIEC on June covering powder machinery, liquid machinery, packaging machinery & material, food safety testing, food dedicated machinery, contact+

Several key topics, relevant to the region, were discussed. In fact, the slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers which are now shifting their focus more on the actual prospects of regional exports. Mirroring this trend, international investors and companies are now pushing for more business in this regional market, across the entire ASEAN economy.

The country has the biggest and fastest growing economy in the SEA region and a pharma economy consisting of over pharmaceutical companies. There are already generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies established in the area. These favourable macro trends are reflected at CPhI South East Asia where domestic manufacturers in particular are increasingly attending the event, with a view to opening up sales in international markets.

As the biggest pharma event in the ASEAN region, CPhI South East Asia will gather over 5, attendees from 41 countries and more than exhibitors click here for the full list to network, learn and do business for three days. Co-locating this year with Health Ingredients South East Asia, the event welcomes the best pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing as well as nutraceutical companies from across the region.

The event’s conference programme is a dedicated, content-enriched platform that will cover business outlook and markets, regulations and compliance, and manufacturing and supply chain.

GoMed2Med BV

The combination of potent, small molecule drugs with the highly target specificity of monoclonal antibodies allows sensitive discrimination between healthy and diseased tissue. This approach has demonstrated great efficacy — and safety — in the fight against cancer and hematological malignancies. Antibody-drug Conjugates are part of a specialized subset of highly potent active pharmaceutical ingredients APIs.

Today, the development of this technically challenging new class of highly potent biopharmaceutical drugs is rapidly expanding. On average, each month more than one new ADC is entering a clinical trial. This progress, as well as the increased development of innovative payloads, novel linkers chemistry and new site-specific conjugation technologies, is creating much excitement among scientists and researchers involved in the development of these specialized, personalized and targeted therapeutics.

CPhI South East Asia is the leading pharmaceutical exhibition in the region, bringing together more than 5, pharma industry professionals from 22+ new suppliers to network, develop new and existing relationships and do business in pharma – all in one location.

But who are the machinery exhibitors? A sneak preview of some of them: Equipment for inspection, drug formulation, filling, and state-of-the-art packaging, leveraging accumulated experience and an extensive know-how in medicine, food, cosmetics, and oil-related fields. Whether you are installing a new kilo lab, pilot plant, or large-scale API manufacturing facility, or if you need to upgrade your existing facility to meet new requirements or regulation, De Dietrich Process Systems can provide a customized solution incorporating containment, CIP, SIP, automation and mixing.

The global leader in the manufacture of innovative Constant temperature equipment and systems for science, application technology and production. Leading provider of sterilization equipment, filling solutions and inspection technology for the pharmaceutical industry. High Fine Engineering China: Mainstream supplier of water system equipment in the global pharmaceutical industry. Leading manufacturer of precision fabrics from monofilaments for the screen printing and filtration markets.

Интервью IPhEB&CPhI Russia 2016: Денис Карпухин, DSM Nutritional Products


Hi! Would you like find a partner for sex? It is easy! Click here, free registration!